Clinical Trial

Efficacy and Safety of LP-005 Injection in Patients With Complement-Mediated Kidney Disease

Name: Efficacy and Safety of LP-005 Injection in Patients With Complement-Mediated Kidney Disease — clinical trial record (NCT07363265)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a multicenter, open-label, proof-of-concept, phase Ⅱ adaptive basket clinical trial designed to evaluate the efficacy, safety, and pharmacokinetic profile of LP-005 Injection as add-on therapy to standard treatment in patients with complement-mediated renal diseases.

Trial Details

NCT Number	NCT07363265
Lead Sponsor	Longbio Pharma
Conditions	Complement-mediated Renal Diseases
Enrollment	46 participants
Start Date	2026-02-02
Primary Completion	2028-08-02 (estimated)
Study Completion	2029-05-02 (estimated)
Updated on ClinicalTrials.gov	2026-01-23